title: Widely used cancer drug associated with significantly increased risk of blood clots.
authors.forename: Les
authors.initials: L
authors.lastname: Lang
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D012306:Risk; D054556:Venous Thromboembolism / Q000139:chemically induced*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab